ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000550.1|Salivaricin_1 # 3 # 485 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.308	BGC0000550.1|Salivaricin_1 	3	485	-	Loose	400	95.9005	vanR gene in vanI cluster	34.84	3003728	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGAATTTCGAAGCGCAGCTATTAAACAAACGGATATTAATAGTAGACGATGATGTTTCACTTAGTAAATCTATTAAAGAAGTTTTGGTGAGCAGGGGATTTAAAAATATTAGTAATGCTTACAGTATTAGCGAAGGAATAGATATTTTTTCTATTTCTAAAATAGATCTCATTATCCTAGATGTAATGTTGCCGGATGGAGAAGGTTATCTACTTGCTCAGTACATCAGAAAAACTTCTGATATACCAATTTTATTTTTAACAGCCAAAAATAATCCAGATGATGAAGTTAAAGGATTAGATTCAGGTGGTGATGACTTTGTCACAAAACCATTTCTTCCAAAAACTTTAATCTATCGTATAATTGCTTTGGTGAGGAGAGCATATAAAGGAGAATCAGAATTAATAACGTTAACTTCTTGTATCATTGATTTAAATAATGCTAGTGTAAAAAAAGAGGAACAGCATTTATCGCTACTCCAA	MNFEAQLLNKRILIVDDDVSLSKSIKEVLVSRGFKNISNAYSISEGIDIFSISKIDLIILDVMLPDGEGYLLAQYIRKTSDIPILFLTAKNNPDDEVKGLDSGGDDFVTKPFLPKTLIYRIIALVRRAYKGESELITLTSCIIDLNNASVKKEEQHLSLLQ	MAANILIVDDEQAIADLVEVYLKNENYNLFKFYNGKDALDCIEKEKLDLAILDVMLPDVDGFSICRQIREKHNFPVIMLTAKEEEIDKITGLTLGADDYITKPFRPLELIARVKAQLRRFTKYNSAEPNQEEHVIAFSGLVLDMDTHECTLNEKKLSLTPTEFSILWVLCSNRGRVVSSEELFSEVWGDKYFTNSNNTVMVHIRHLREKMQDSAEHPKYIKTVWGVGYKIEK	69.40	gnl|BL_ORD_ID|2065|hsp_num:0	2246			12	474	vancomycin; teicoplanin
BGC0000550.1|Salivaricin_2 # 743 # 892 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.347	BGC0000550.1|Salivaricin_2 	743	892	+	Loose	400	20.7866	ErmB	35.48	3000375	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAAAAAAGATGTAGTTATCGAATCAATTAAAGAAGTAAGTCTTGAAGAGCTTGATCAAATTATTGGAGCTGGGAACGGTGTGTTTAAAACTATCTCACATGAGTGTCATCTTAATACCTGGGCATTTCTTGCTACATGTTGCTCATAA	MKKDVVIESIKEVSLEELDQIIGAGNGVFKTISHECHLNTWAFLATCCS	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYNLSTQIIKKVVFESRASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLLFNGRKLIL	19.76	gnl|BL_ORD_ID|1424|hsp_num:0	1549			42	135	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000550.1|Salivaricin_4 # 1317 # 1475 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.333	BGC0000550.1|Salivaricin_4 	1317	1475	+	Loose	1100	21.1718	oleB	45.45	3003036	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGAAAAATAATAAAATTCATCTAGAAGCTTTGGAAGCGTTACAAGAACTAAAAATGGAAGAAATAGATAATCTTTTGGGCGGAGCTGGTCATGGAGTAAATACTATTTCTGCTGAATGTCGTTGGAATAGCTTACAAGCTATCTTTACCTGTTGTTAA	MKNNKIHLEALEALQELKMEEIDNLLGGAGHGVNTISAECRWNSLQAIFTCC	MQNAHRSDTGAAALTGTPEKLLPTQPETGSFQVVLDDVVRAPGGRPLLDGVNQSVALGERVGIIGENGSGKSTLLRMLAGVDRPDGGQVLVRAPGGCGYLPQTPDLPPEDTVQDAIDHALAELRSLERGLREAEQALAGAEPEELEGLLGAYGDLLEAFEARDGYAADARVDAAMHGLGLAGITGDRRLGSLSGGEQARLNLACLLAASPQLMLLDEPTNHLDVGALEWLEERLRAHRGSVLVVSHDRVFLERVATALWEVDGERRTVNRHGGGYAGYLQAKAAARRRWEQAYQDWLEDLARQRELARSAADHLATGPRRNTERSNQRHQRNVEKQISARVRNAKERVRRLEENPVPRPPQPMRFRARVEGGGTVGRGGALAELYKVTVGTRLDVPSFTVDPGERILITGHNGAGKSTLLRVLAGDLAPDQGECERPERIGWLPQETEITDRQQSLLAAFAAGLPGIAEEHRGALLGFGLFRPSALGTAVGDLSTGQLRRLALARLLRDPADLLLLDEPTNHLSPALVEDLEEALAHYRGALVVVSHDRMFAQRFTGRRMHMEGGRFVE	9.14	gnl|BL_ORD_ID|1272|hsp_num:0	1388			393	459	oleandomycin
BGC0000550.1|Salivaricin_5 # 1495 # 2397 # 1 # ID=1_5;partial=01;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.289	BGC0000550.1|Salivaricin_5 	1495	2397	+	Loose	450	30.0314	Erm(O)-lrm	33.33	3004652	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAATCATCAAGAACAATTATATAGTCAGTTTAATAAATTTCCTAAAGTTTTTATTGAAAAGAAAATACCTGAAGTTCTTAATGAGGATGTTAAGGTACTAAAACAGGTTGAGAAAAATATATCAGACTATTATCGATCTACATTAATTTATTTGATTAACGAAAAACGTATTGAAGGGAAGTTAATTGGCGACACAGCTGAGCTACGATATGATTATTTTAATAATGTATTATGTAAAAATGGTGATATTTTAGAAGAAATAGAGGAAAGATTTCCGACTATTAGTCAACGTGTCATCATCAGTATAGAGCAGTACCTTGATTTGCTTAAATGCGTAAAAAAACATTTTTCAATAGACTTTTCAATATTGAAAAAAATAAAATTTATTTGCTCAGATGATGAAAATCCTAATTTAAACAATCTTGATATTAAAGTAACAGGTGATATTCATAATGGAAGTGGTGTTTGTATTTTATCTTATGATGGACAAAAATTAGTTTATAAGAAAAAATCGTCAAAACCAAATCATCTTTTAAAAAAATTGGATAATCAAGTTAGCAAGTATTTAAAAAAAGAGATTCAGTTTGTACCTGACTTTTTAGATAGGGAAGGTTACTTTTGGGAAACTTTTATAGACAGTAAGCCAGTTTGTTCGATTGATGAAGCGAAAGAGTTTTATAAAAGAATGGGTTATCTTGTAGCATATGCTTACATTTTAAATATTTCTGACTTGCATTTCGAAAATCTTATTTCACATAATGTTCAGCCTATCCTAGTCGATGCTGAGACAGTATTTTCTGTAAGTCCGTATGAAACAGTAGCGGATAATAATGCTACTTTAGAGATAATTCGGGATAGCAGAAATTCAGTACTATCTACAGGATTGTTACCTGTGTCTGAA	MNHQEQLYSQFNKFPKVFIEKKIPEVLNEDVKVLKQVEKNISDYYRSTLIYLINEKRIEGKLIGDTAELRYDYFNNVLCKNGDILEEIEERFPTISQRVIISIEQYLDLLKCVKKHFSIDFSILKKIKFICSDDENPNLNNLDIKVTGDIHNGSGVCILSYDGQKLVYKKKSSKPNHLLKKLDNQVSKYLKKEIQFVPDFLDREGYFWETFIDSKPVCSIDEAKEFYKRMGYLVAYAYILNISDLHFENLISHNVQPILVDAETVFSVSPYETVADNNATLEIIRDSRNSVLSTGLLPVSE	MARPTQRARTLSQNFLADRATAERVARLAVPDRGRPPLLLEVGAGNGALTEPLARRSRELHAYEIDPRLVPGLRARFARSPHVHVVAGDFLTARPPRTPFAVAGNVPFSRTADIVDWCLTAPGLTDATLLTQLEYARKRTGDYGRWTLLTVLTWPRHEWRLVGRVGRSRFCPAPRVDAGILRIERRPTALLTGAAARRDWADLVELGFSGVGGSLHASLRRAHSRRRVDAAFRAARLDPGVLVGEVAPDRWLRLHEELTA	115.77	gnl|BL_ORD_ID|2181|hsp_num:0	3351			375	510	erythromycin; lincomycin; tylosin
